Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HCW Biologics (HCWB) Operating Income (2021 - 2025)

Historic Operating Income for HCW Biologics (HCWB) over the last 5 years, with Q3 2025 value amounting to -$3.3 million.

  • HCW Biologics' Operating Income rose 1065.03% to -$3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.9 million, marking a year-over-year increase of 6792.92%. This contributed to the annual value of -$29.5 million for FY2024, which is 1463.03% down from last year.
  • HCW Biologics' Operating Income amounted to -$3.3 million in Q3 2025, which was up 1065.03% from -$3.5 million recorded in Q2 2025.
  • Over the past 5 years, HCW Biologics' Operating Income peaked at -$1.9 million during Q1 2022, and registered a low of -$15.1 million during Q2 2024.
  • Moreover, its 5-year median value for Operating Income was -$3.7 million (2024), whereas its average is -$4.9 million.
  • Per our database at Business Quant, HCW Biologics' Operating Income plummeted by 23557.12% in 2024 and then soared by 7711.37% in 2025.
  • Over the past 5 years, HCW Biologics' Operating Income (Quarter) stood at -$3.1 million in 2021, then crashed by 82.08% to -$5.7 million in 2022, then crashed by 90.01% to -$10.8 million in 2023, then surged by 70.56% to -$3.2 million in 2024, then fell by 3.83% to -$3.3 million in 2025.
  • Its Operating Income was -$3.3 million in Q3 2025, compared to -$3.5 million in Q2 2025 and -$2.0 million in Q1 2025.